An exploration of therapeutic evaluation of traditional Chinese medicine in treatment of hepatic fibrosis
10.3969/j.issn.1001-5256.2017.05.006
- VernacularTitle:中医药抗肝纤维化疗效评价的探索
- Author:
Lieming XU
- Keywords:
liver cirrhosis;
Chinese patent drugs;
treatment outcome
- From:
Journal of Clinical Hepatology
2017;33(5):825-828
- CountryChina
- Language:Chinese
-
Abstract:
China has become one of the leading counties in the world to treat hepatic fibrosis with Chinese patent drugs.The therapeutic effect of traditional Chinese medicine (TCM) should be evalvated from the aspects of short-term therapeutic effect,long-term therapeutic effect,and effect of relief of symptoms.This article introduces the results of our exploration of the application of liver stiffness measurement to evaluate therapeutic effect,five-year survival rate to assess]ong-term therapeutic effect,and a TCM syndrome scale to evaluate effect of relief of symptoms,suggesting that the Chinese patent drug Fuzheng Huayu capsules/tablets have a marked clinical effect in the treatment of hepatic fibrosis.It is recommended to use serological diagnostic models,conduct prospective studies with long-term follow-up,and analyze the samples and data accumulated over a long period of time,in order to perfect the methods for evaluating the outcome of hepatic fibrosis.
